12th February 2021 Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related
Read More12 Feb
Delicate balance needed to maximise opioid substitution treatment
Tag: EMCDDA
18 Dec
New report highlights wide-ranging impacts of EU drug markets on health and security
People in Europe are spending at least 30 billion Euros on drugs each year at retail level, making the drug
Read More27 Sep
Brexit poses a “severe threat” to access to EMCDDA and EUROPOL
Specialists in substance use and public health have warned that Brexit poses a “severe threat” to shared knowledge of emerging
Read More15 May
Two new synthetic cannabinoids to be placed under control across the EU
The European Union has decided to subject two new synthetic cannabinoids to control measures across the 28 Member States. Harmful
Read More01 May
Timeline of darknet markets visualised in EMCDDA poster
The European Drugs Agency (EMCDDA) and Europol have produced a timeline poster on the lifetimes and reasons for closure of
Read More22 Nov
New European legislation to bring faster response to new drugs
Europe’s ability to rapidly respond to public health and security threats caused by new psychoactive substances (NPS) will be significantly
Read More09 Nov
New policy and practice additions to the EMCDDA ‘Best Practice’ portal
A number of new policy and practice briefings have been added to the European Monitoring Centre for Drugs and Drug
Read More24 Oct
EMCDDA publishes its first European guide on responding to drug problems
A new European guide has been published by the EU Drugs Agency (EMCDDA), which includes the agency’s first overview of
Read More12 Jul
Assessment of high drug-related deaths in Scotland and six other EU countries published
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have published a technical report assessing drug-related deaths (DRD) in
Read More13 Jun
Vulnerable groups in Europe experiencing high levels of harm through use of New Psychoactive Substances
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published a new rapid communication report on high-risk drug
Read More